日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version)

S1 指南“腰椎穿刺和脑脊液分析”(节选及翻译版)

Tumani, H; Petereit, H F; Gerritzen, A; Gross, C C; Huss, A; Isenmann, S; Jesse, S; Khalil, M; Lewczuk, P; Lewerenz, J; Leypoldt, F; Melzer, N; Meuth, S G; Otto, M; Ruprecht, K; Sindern, E; Spreer, A; Stangel, M; Strik, H; Uhr, M; Vogelgsang, J; Wandinger, K-P; Weber, T; Wick, M; Wildemann, B; Wiltfang, J; Woitalla, D; Zerr, I; Zimmermann, T

Optical coherence tomography-based assessment of retinal vascular pathology in cerebral small vessel disease.

基于光学相干断层扫描的脑小血管病视网膜血管病变评估

Abdelhak A, Huss A, Brück A, Sebert U, Mayer B, Müller H P, Tumani H, Otto M, Yilmazer-Hanke D, Ludolph A C, Kassubek J, Pinkhardt E, Neugebauer H

Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis

作者更正:血清GFAP作为多发性硬化症疾病严重程度的生物标志物

Abdelhak, A; Huss, A; Kassubek, J; Tumani, H; Otto, M

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature

MOG-IgG在原发性和继发性慢性进展型多发性硬化症中的作用:一项纳入200例患者的多中心研究及文献综述

Jarius, S; Ruprecht, K; Stellmann, J P; Huss, A; Ayzenberg, I; Willing, A; Trebst, C; Pawlitzki, M; Abdelhak, A; Grüter, T; Leypoldt, F; Haas, J; Kleiter, I; Tumani, H; Fechner, K; Reindl, M; Paul, F; Wildemann, B

Serum GFAP as a biomarker for disease severity in multiple sclerosis

血清GFAP作为多发性硬化症疾病严重程度的生物标志物

Abdelhak, A; Huss, A; Kassubek, J; Tumani, H; Otto, M

The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis

神经梅毒患者的脑脊液中趋化因子CXCL13水平升高

Dersch, R; Hottenrott, T; Senel, M; Lehmensiek, V; Tumani, H; Rauer, S; Stich, O

[Current cerebrospinal fluid diagnostics for pathogen-related diseases]

[目前脑脊液中病原体相关疾病的诊断方法]

Süssmuth, S D; Brettschneider, J; Spreer, A; Wick, M; Jesse, S; Lewerenz, J; Otto, M; Tumani, H

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

伴有帕金森综合征的tau蛋白病:临床表现、神经病理学基础、生物标志物和治疗方案

Ludolph, A C; Kassubek, J; Landwehrmeyer, B G; Mandelkow, E; Mandelkow, E-M; Burn, D J; Caparros-Lefebvre, D; Frey, K A; de Yebenes, J G; Gasser, T; Heutink, P; Höglinger, G; Jamrozik, Z; Jellinger, K A; Kazantsev, A; Kretzschmar, H; Lang, A E; Litvan, I; Lucas, J J; McGeer, P L; Melquist, S; Oertel, W; Otto, M; Paviour, D; Reum, T; Saint-Raymond, A; Steele, J C; Tolnay, M; Tumani, H; van Swieten, J C; Vanier, M T; Vonsattel, J-P; Wagner, S; Wszolek, Z K

Applying new research criteria for diagnosis of early Alzheimer's disease: sex and intelligence matter

应用新的研究标准诊断早期阿尔茨海默病:性别和智力至关重要

Beinhoff, U; Tumani, H; Riepe, M W